ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)

ImmuneOncia Therapeutics Statistics

Total Valuation

KOSDAQ:424870 has a market cap or net worth of KRW 390.41 billion. The enterprise value is 371.47 billion.

Market Cap	390.41B
Enterprise Value	371.47B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:424870 has 74.36 million shares outstanding. The number of shares has increased by 24.14% in one year.

Current Share Class	74.36M
Shares Outstanding	74.36M
Shares Change (YoY)	+24.14%
Shares Change (QoQ)	-0.39%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	n/a
Float	17.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6,567.62
PB Ratio	16.89
P/TBV Ratio	20.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-13.01
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.94

Financial Position

The company has a current ratio of 5.39, with a Debt / Equity ratio of 0.00.

Current Ratio	5.39
Quick Ratio	4.91
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-6,216.22

Financial Efficiency

Return on equity (ROE) is -134.20% and return on invested capital (ROIC) is -85.60%.

Return on Equity (ROE)	-134.20%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-85.60%
Return on Capital Employed (ROCE)	-123.65%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.35% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-19.35%
50-Day Moving Average	7,050.40
200-Day Moving Average	7,960.55
Relative Strength Index (RSI)	35.59
Average Volume (20 Days)	427,096

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:424870 had revenue of KRW 59.44 million and -28.54 billion in losses. Loss per share was -391.78.

Revenue	59.44M
Gross Profit	45.62M
Operating Income	-29.23B
Pretax Income	-28.54B
Net Income	-28.54B
EBITDA	-28.38B
EBIT	-29.23B
Loss Per Share	-391.78

Balance Sheet

The company has 18.99 billion in cash and 55.70 million in debt, with a net cash position of 18.94 billion or 254.67 per share.

Cash & Cash Equivalents	18.99B
Total Debt	55.70M
Net Cash	18.94B
Net Cash Per Share	254.67
Equity (Book Value)	23.12B
Book Value Per Share	312.71
Working Capital	17.15B

Cash Flow

In the last 12 months, operating cash flow was -26.30 billion and capital expenditures -348.16 million, giving a free cash flow of -26.65 billion.

Operating Cash Flow	-26.30B
Capital Expenditures	-348.16M
Depreciation & Amortization	850.23M
Net Borrowing	-52.17M
Free Cash Flow	-26.65B
FCF Per Share	-358.33

Margins

Gross Margin	76.74%
Operating Margin	-49,179.97%
Pretax Margin	-48,017.87%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:424870 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.14%
Shareholder Yield	-24.14%
Earnings Yield	-7.31%
FCF Yield	-6.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:424870 has an Altman Z-Score of 66.23 and a Piotroski F-Score of 1.

Altman Z-Score	66.23
Piotroski F-Score	1